Résumé
Hyperosmotic stress promotes rapid and pronounced apoptosis in cultured cardiomyocytes. Here, we investigated if Ca2+ signals contribute to this response. Exposure of cardiomyocytes to sorbitol [600 mosmol (kg water)-1] elicited large and oscillatory intracellular Ca2+ concentration increases. These Ca2+ signals were inhibited by nifedipine, Cd 2+, U73122, xestospongin C and ryanodine, suggesting contributions from both Ca2+ influx through voltage dependent L-type Ca 2+ channels plus Ca2+ release from intracellular stores mediated by IP3 receptors and ryanodine receptors. Hyperosmotic stress also increased mitochondrial Ca2+ levels, promoted mitochondrial depolarization, reduced intracellular ATP content, and activated the transcriptional factor cyclic AMP responsive element binding protein (CREB), determined by increased CREB phosphorylation and electrophoretic mobility shift assays. Incubation with 1 mM EGTA to decrease extracellular [Ca2+] prevented cardiomyocyte apoptosis induced by hyperosmotic stress, while overexpression of an adenoviral dominant negative form of CREB abolished the cardioprotection provided by 1 mM EGTA. These results suggest that hyperosmotic stress induced by sorbitol, by increasing Ca2+ influx and raising intracellular Ca2+ concentration, activates Ca2+ release from stores and causes cell death through mitochondrial function collapse. In addition, the present results suggest that the Ca2+ increase induced by hyperosmotic stress promotes cell survival by recruiting CREB-mediated signaling. Thus, the fate of cardiomyocytes under hyperosmotic stress will depend on the balance between Ca2+-induced survival and death pathways.
Langue d'origine | English |
---|---|
Pages (de-à) | 887-903 |
Nombre de pages | 17 |
Journal | Apoptosis : an international journal on programmed cell death |
Volume | 15 |
Numéro de publication | 8 |
DOI | |
Statut de publication | Published - août 2010 |
Financement
Acknowledgments We thank Fidel Albornoz and Ruth Marquez for their technical assistance and Drs Paola Llanos and David Mears (Faculty of Medicine, Universidad de of Chile, Santiago, Chile) for their help with fura2-AM experiments. This work was supported by FONDAP (Fondo de Areas Prioritarias, Fondo Nacional de Desarrollo Cientifico y Tecnologico, CONICYT, Chile) grant 15010006 (to S. L., C. H., E. J.). We also thank the International Collaboration Program ECOS-CONICTY grants C04B03 and C08S01 (to G. K. and S. L.) and FONDECYT Postdoctoral Grant 3070043 (to V. E.). C. M., C. I., V. P., R. B., C. Q., A. C. and J. M. V. are recipients of Ph. D. fellowships from CONICYT, Chile. S. L. is in a sabbatical leave at The University of Texas Southwestern Medical Center, Dallas.
Bailleurs de fonds | Numéro du bailleur de fonds |
---|---|
Comisión Nacional de Investigación Científica y Tecnológica | C08S01, 15010006, C04B03 |
Fondo Nacional de Desarrollo Científico y Tecnológico | 3070043 |
Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias |
ASJC Scopus Subject Areas
- Pharmacology
- Pharmaceutical Science
- Clinical Biochemistry
- Cell Biology
- Biochemistry, medical
- Cancer Research